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©2010 The Japan Society of Histochemistry and Cy- Adipose derived stromal cells (ADSCs) were transplanted into a developing mouse eye to
investigate the influence of a developing host micro environment on integration and differ-
entiation. Green fluorescent protein-expressing ADSCs were transplanted by intraocular
injections. The age of the mouse was in the range of 1 to 10 days postnatal (PN). Survival
dates ranged from 7 to 28 post transplantation (DPT), at which time immunohistochemistry
was performed. The transplanted ADSCs displayed some morphological differentiations in
the host eye. Some cells expressed microtubule associated protein 2 (marker for mature
neuron), or glial fibrillary acid protein (marker for glial cell). In addition, some cells integrated
into the ganglion cell layer. The integration and differentiation of the transplanted ADSCs in
the 5 and 10 PN 7 DPT were better than in the host eye the other age ranges. This study
was aimed at demonstrating how the age of host micro environment would influence the
differentiation and integration of the transplanted ADSCs. However, it was found that the
integration and differentiation into the developing retina were very limited when compared
with other stem cells, such as murine brain progenitor cell.
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I. Introduction
Mesenchymal stem cells (MSCs) represent a popula-
tion of adult stem cells. MSCs have a limited ability for
differentiation in comparison to embryonic stem cells.
However, unlike the the latter, they do not have the ethical
problem, immune rejection response or tumor formation.
Further, they also possess the advantages of efficiency and
stability [8, 24, 46, 52]. MSCs were first found to originate
in osteoprogenitor cells. Subsequently, the differentiation
of MSCs into adipocytes, chondrocytes, osteoblasts, and
myoblasts in vitro and in vivo has been diversely reported.
MSCs are also viewed as promising candidates for meso-
dermal defect repair and disease management [6, 13, 33].
In addition, various researches have proven that MSCs can
differentiate into neuronal cells [25, 45, 50]. However, this
approach faces some difficulties in linical application as
it involves painful surgical procedures for the donor to
obtain the bone marrow MSCs (BM-MSCs). Further, the
BM-MSCs present problems of morbidity and have a low
number of cells upon harvest [34, 52]. These limitations
have facilitated the investigation of alternative sources of
BM-MSCs.
Adipose derived stromal cells (ADSCs) have gained
considerable attention as a new cell line for surmounting
the limitations of BM-MSCs. Some advantages of ADSCs
in comparison to BM-MSCs are as follows: 1) the surgical
procedures for obtaining ADSCs are less invasive than those
for BM-MSCs; 2) ADSCs can be obtained 100,000 cells per
1 g of adipose, whereas BM-MSCs are obtained only per
0.01% of bone marrow nucleated cells; and 3) massive
multiplication of ADSCs is possible [34, 40]. A recent
comparative study between ADSCs and BM-MSCs reported
that the features of ADSCs are by and large similar to those
of BM-MSCs. However, the ability of ADSCs to proliferate
is better than that of BM-MSCs. It was also reported that
the acquisition process of ADSCs is simpler because theyYu et al. 124
can be easily separated by enzymes and their morbidity is
also lower than that of BM-MSCs [21, 23, 35]. In view of
these advantages, ADSCs are now being recognized as a
potentially good material for stem cell transplantation therapy.
The retina, which is a representative of the central
nervous system, contains various neurons. Diseases caused
by damaged and extinct retinal neurons, such as, macular
degeneration, glaucoma, and retinitis pigmentosa, are clas-
sified as incurable retinal diseases. A practical strategy is
considered which involves transplanting the stem/progenitor
cells that support the cells involved in neuronal protection to
replace the damaged retinal neurons caused by such diseases
as well as for other reasons. The results obtained from
research [18, 43] indicated that the neuronal cells survived
and integrated into the retina when they were transplanted
into the vitreous chamber or the subretinal space using the
neuronal stem/progenitor cells derived from the brain
and the retina. Interestingly, the researchers also found that
the BM-MSCs differentiated into photoreceptors under a
specific environment [17, 19, 43, 44].
The developing mouse was selected as the animal
model in the present study. This is because the mouse breeds
easily and is also amenable to genetic analyses. In addition,
the mouse has incomplete eyes after birth and its retina
formation for functional vision is in progress [7]. The eye
development of a mouse is also relatively well known. In
view of these facts, the mouse is the best animal model for
stem cell research into the developing eye. In developing
stages, various signaling factors involved in neuronal differ-
entiation are activated in the retina and vitreous chamber [1–
4, 9, 29, 32, 49]. Accordingly, it was known that multiple
factors at each specific developing step would influence the
differentiation into the different cell type and that they help
to maintain a proper micro environment. Several researches
have reported on the importance of specific micro environ-
ment for stem cell therapy [37, 48] and, especially, some
signaling factors relating to developing stage are already
known as key factors for stem cell therapy [26, 39, 47]. For
these reasons, we supposed that some special micro environ-
ments during developing stages aided the differentiation and
integration of the transplanted stem cells into the developing
retina.
The goal of the present study was 1) to suggest the
usefulness of the ADSCs for stem cell therapy in the devel-
oping eye, replacing BM-MSCs because of their several
problems as mentioned above, and 2) to provide certain
helpful tips to achieve the best micro environment for stem
cell transplantation therapy by determining the degrees of
the differentiation and integration of stem cell according to
the different developing stages in the mouse eye.
II. Materials and Methods
Experimental animals
The guidelines of the National Institutes of Health
regarding the Care and Use of Laboratory Animals were
diligently followed in all experimental procedures. Mice
(C57/BL6) were used in this study. Pups of ages 1, 5, and
10 days PN were used. Pups receiving transplantation were
allowed to survive for 7, 14, and 28 DPT. Fifteen pups were
allocated at each survival time so that 45 pups in total were
used at each developing stage.
Cell culture and labeling
Human ADSCs (Cat# SV30102, Cellular Engineering
Technologies Inc., Coralville, IA, USA) were used. ADSCs
were obtained from the laboratory of Dr. D-H Hwang (CHA
University). The cells were cultured in a medium contain-
ing α-MEM (Invitrogen Corp., Carlsbad, CA, USA), 10%
fetal bovine serum (FBS, Invitrogen), 2 mM L-Glutamine
(Invitrogen), and 1% Antibiotic-Antimycotic (Invitrogen).
ADSCs were labeled with Lenti hCMV-GFP-IRES puro
(Macrogen Inc., Seoul, Korea) in order to identify the cell
after transplantation. ADSCs were infected with a stock
lenti-virus concentration of 2×106 infection units/μl. The in-
fection efficiency is approximately more than 80% (Fig. 1).
Fig. 1. The transduction efficiency of lentiviral vector in the adipose derived stromal cells. (A) Merged image of the differential interference
micrograph and DAPI staining picture of adipose derived stromal cells. (B) Merged image of the GFP positive cells and DAPI staining of the
adipose derived stromal cells. Arrowheads indicate cells that are not GFP positive. Bar=50 μm.Transplantation of Adipose Derived Stromal Cells 125
Transplantation of ADSCs into the developing retina
Animals were anesthetized using a mixture of ketamine
hydrochloride (30–40 mg/kg) and xylazine (3–6 mg/kg).
Pups of 1, 5, and 10 PN received intraocular ADSCs injected
through the dorsolateral aspect of the eye using a 30 gauge
Hamilton syringe (Hamilton Co., Reno, NV, USA). One μL
of cell suspension (~50,000 cells/μl) was slowly injected
into the vitreous chamber of the pups. Pups receiving the
transplanted ADSCs were allowed to survive for 7, 14, and
28 DPT.
Tissue preparation and immunohistochemistry
Tissue fixation, sectioning, and immunohistochemistry
were performed, as previously described [48]. The heads
(pups) and eyes (young mice) were quickly removed, fixed
with 4% paraformaldehyde in 0.1 M phosphate buffer, and
then cryoprotected in a series of 10, 20, and 30% sucrose in
0.1 M phosphate buffer. The tissue was embedded (Tissue-
Tek; OCT compound; VWR International, West Chester,
PA, USA), frozen, and sectioned coronally at 20 μm thick-
ness using a cryostat. The sections were thaw-mounted onto
Superfrost microscope slides (Fisher Scientific, Pittsburgh,
PA, USA) and stored at −20°C until further processing. The
primary antibodies and the concentration were as follows;
mouse anti-MAP2ab antibody (mature neuronal cell marker,
1:300, Abcam Inc., Cambridge, MA, USA), mouse anti-
GFAP antibody (glial cell marker, 1:300, Abcam), and
rabbit anti-GFAP antibody (glial cell marker, 1:500, Sigma,
St Louis, MO, USA). The standard immunocytochemical
techniques and immunohistochemical methods have been
described previously in detail [48]. For detection by immuno-
fluorescence, the secondary antibody Cy3 conjugated anti-
mouse (1:200, Jackson ImmunoResearch Lab., West Grove,
PA, USA) and Cy3 conjugated anti-rabbit (1:200, Jackson
ImmunoResearch Lab.) were used. After immunohisto-
chemistry, the tissues were stained with DAPI (1:500,
Sigma). The labeled tissues were coverslipped with a
Vectashield mounting medium (Vector Lab. Burlingame,
CA, USA).
Data analysis
The retina tissues transplanted with ADSCs were com-
pared with the control retina tissues and the normal develop-
ment of the retina transplanted ADSCs was examined. The
labeled tissues were examined and photographed using a
Zeiss Axioplan microscope with high power differential
interference contrast (DIC) optics. The images were viewed
on a computer monitor using a Zeiss Plan-Apochromat
100× objective and a Zeiss AxioCam HRc digital camera
(Carl Zeiss Meditec Inc., Jena, Germany).
III. Results
Cellular differentiation of the transplanted ADSCs in the 
developing mouse eye
Several transplanted ADSCs were found in the host eye
of 5 and 10 PN 7 DPT. In Figures 2A, C and E, they showed
DAPI labeling images. The transplanted ADSCs at 5 PN 7
DPT are illustrated in Figures 2B and D. In Figure 2B, it can
be observed that the ADSCs differentiated morphologically
into the cell with bidirectional dendrites (arrow) and multi-
polar processes (arrowhead). In Figure 2D, it can be seen
that the transplanted ADSCs displayed morphological dif-
ferentiation with the branched processes emerging from
the primary process. The transplanted ADSCs at 10 PN 7
DPT are illustrated in Figures 2E and G. In Figure 2E, it
can be seen that the transplanted ADSCs differentiated
morphologically into the multipolar stellate cell with the
processes oriented in several directions in the ganglion cell
layer (GCL). In Figure 2G, it can be observed that the
transplanted ADSCs displayed morphological differentia-
tion into the cell with horizontally-oriented long bidirec-
tional processes.
Antibodies directed against MAP2ab and GFAP were
used to determine whether the transplanted ADSCs ex-
pressed differentiated markers within the environment of
the eye. A subpopulation of the GFP immunoreactive cells
was clearly found to co-express MAP2ab (microtubule-
associated protein 2 which is found in mature neurons) and
GFAP (glial fibrillary acid protein present in glial cells).
The transplanted ADSCs at 10 PN 7 DPT are illustrated in
Figures 3A–L, and the transplanted ADSCs at 5 PN 7 DPT
are illustrated in Figures 3M–O.
In Figures 3A–F, the transplanted ADSC in the GCL
expressed MAP2ab, while the transplanted ADSC in the
vitreous chamber expressed MAP2ab in Figures 3G–I.
Lastly, it can be seen that in Figures 3J–L, the transplanted
ADSC in the GCL expressed GFAP, while in Figures 3M–
O, the transplanted ADSC in the vitreous chamber expressed
GFAP.
Integration of the transplanted ADSCs into the developing 
mouse retina
The transplanted ADSCs integrated into the developing
mouse retina are illustrated in Figure 4. In Figures 4A, C and
E, they showed the DIC images which correspond to each
fluorescent image. The transplanted ADSCs at 5 PN 7 DPT
retina are illustrated in Figures 4B and D. In Figure 4B, it
can be seen that the ADSCs integrated into the GCL and
morphologically differentiated with horizontally-oriented
long processes. In Figure 4D, the transplanted ADSCs
integrated into the GCL and morphologically differentiated
into a horizontally-oriented, spindle shaped cell body, with
long branched processes. In Figure 4F, it can be seen that
the transplanted ADSCs differentiated morphologically into
the multipolar stellate cell.
In the present study, there was a limited availability of
ADSCs to integrate into the retina. Thus, it was not possible
to determine whether the transplanted ADSCs integrated
into the inner nuclear layer (INL) and the outer nuclear layer
(ONL). The most effective transplantation stage and the
duration time of the transplanted ADSCs in the retina are
shown in Table 1. It can be observed that the differentiation
and integration of ADSCs mainly occurred at 5, 10 PNYu et al. 126
rather than 1 PN. These results indicate that the host micro
environment, depending on the development stage, influ-
ences the transplantation and integration of ADSCs. In
addition, except for 7 DPT, the differentiation and integra-
tion of the transplanted ADSCs were rarely observed in
the case of 14, 28 DPT. Thus, it was concluded that the
transplanted ADSCs did not survive for a long duration of
time.
IV. Discussion
The present study was carried out to determine whether
the transplanted ADSCs can be morphologically integrated
and molecularly differentiated into the retina of a developing
mouse. Further, the study also examined how the host micro
environment in the developing mouse eye would influence
the transplanted ADSCs.
Some researches have demonstrated ADSCs to exhibit
the potential for stem cell therapy. For example, ADSCs
transplanted into the myocardial scar tissue formed cardiac
islands and vessel-like structures that induced angiogenesis,
thereby improving the cardiac function and vasculogenesis
[28, 51]. In addition, the ADSCs also differentiated into the
neuronal cells. Although studies about ADSCs differentiated
into the neuronal cells in vivo are not sufficient, some
researches suggest that ADSCs exhibited a capability of
differentiation into the neuronal cells in vitro [10, 36]. In
addition, it was also reported that the intracerebral trans-
plantation of ADSCs after cerebral ischemia in rats could
improve the neurological deficit [15]. In the present study
Fig. 2. Morphological differentiation of transplanted
adipose derived stromal cells. (A, C, E, G) Images of
DAPI staining (B) The transplanted adipose derived
stromal cells morphologically differentiated into the
cell with bidirectional dendrites (arrow) and multi-
polar processes (arrowhead) in the vitreous chamber.
(D) The transplanted adipose derived stromal cell
illustrated the morphological differentiation into cells
with branched processes in the vitreous chamber. (F)
The transplanted adipose derived stromal cell mor-
phologically differentiated into the multipolar cell in
the ganglion cell layer. (H) The transplanted adipose
derived stromal cell illustrated the morphological dif-
ferentiation into the cell with bidirectional dendrites
in the vitreous chamber. (A–D) 5 PN 7 DPT, (E–H)
10 PN 7 DPT. Bar=20 μm.Transplantation of Adipose Derived Stromal Cells 127
Fig. 3. Cellular differentiation of transplanted adipose derived
stromal cells. (A, D, J) GFP-expressing human adipose derived
stromal cells in the ganglion cell layer. (G, M) GFP-expressing
human adipose derived stromal cells in the vitreous chamber.
(B, E, H) MAP2ab-immunoreactive adipose derived stromal cells.
(K, N) GFAP-immunoreactive human adipose derived stromal
cells. (C, F, I, L, O) Merged images (A–L) 10 PN 7 DPT, (M–O)
5 PN 7 DPT. Bar=20 μm.
Fig. 4. Integration of transplanted adipose derived stromal cells. (A,
C, E) Merged image of the differential interference micrograph and
DAPI staining picture of the integrated adipose derived stromal
cells in ganglion cell layer. Asterisks indicate GFP+ cell bodies. (B
and D) The transplanted adipose derived stromal cell integrated
into the ganglion cell layer at 5 PN 7 DPT retina. (F) The trans-
planted adipose derived stromal cell integrated into the ganglion
cell layer at 10 PN 7 DPT retina. Bar=20 μm.Yu et al. 128
it was suggested that the transplanted ADSCs differentiated
in the developing eye. It was observed that, although the
transplanted ADSCs did not integrate into the other retinal
cell layer, except in the GCL, the transplanted ADSCs mor-
phologically differentiated and fully displayed an ability of
differentiation into the various retinal cell types, thereby
showing expressions of MAP2ab and GFAP.
Some transplantation researches have used the different
cell lines into the eye. Lamba et al. (2009) demonstrated
that the embryonic stem cell can differentiate into the retinal
cells and be used as a therapy for retinal diseases [20].
However, the embryonic stem cell presents some problems
which must be solved, such as ethical issues, immune rejec-
tion response, and tumor formation. Researches using the
neural stem/progenitor cells such as mBPC (murine brain
progenitor cell), mRPC (murine retinal progenitor cell) and
AHPC (adult rat hippocampal progenitor cell), have also
been published [31, 37, 38, 41, 48]. When the mBPCs were
transplanted [48], they functionally integrated into several
cell layers of the retina and morphologically differentiated
into a retinal cell-like shape. In addition, mBPC expressed
MAP2 which has been used to identify the neuronal cells,
and calretinin which has been used as a marker of a subclass
of horizontal, amacrine and ganglion cells. In addition, the
mBPCs also expressed the recoverin protein. Further, BM-
MSCs differentiated into the various retinal cells [44] and
delayed the retinal degeneration in the RCS (Royal College
of Surgeons) rat model of retinal degeneration [14]. When
the BM-MSCs were transplanted into the rat eye, injured by
ischemia/reperfusion, they did not migrate well. However, a
few cells integrated into the GCL and lowered the reduction
of the ganglion cell [22].
In the present study, it was demonstrated that the
transplanted ADSCs morphologically differentiated and
displayed the expression of the neuronal cell and glial cell
markers and integrated into the GCL. The molecular and
morphological differentiation and the retinal integration
were limited in this study when compared to the embryonic
stem cell and the neural stem/progenitor cell. However, the
ability of molecular and morphological differentiation and
integration in the retina was clearly demonstrated. Thus,
ADSCs are considered as one of the candidates for effective
therapeutic research in the future.
During the developing stage, diverse signaling is in-
volved in regulation of the gene expression, formation and
development of the necessary organ. The mouse has incom-
plete eyes after birth and its retina formation for functional
vision is in progress [7]. Consequently, in the developing
mouse eye, various signaling factors, such as Wnt, Shh,
BMP and FGF, related with development are active [1, 9,
49]. The morphogenetic signals are recycled, which provide
guidance information to retinal ganglion cell axons during
their growth toward their synaptic targets [5]. FGF signaling
also contributes in positioning the presumptive retinal cells
in the right place at the right time [30]. In addition, even if
the evidence is still insufficient for age-dependent expres-
sion profile of ocular growth factors or cytokines in the
vitreous fluid, diverse factors such as VIGF, IGF-1, GH,
TGFβ and EGF are involved with survival and differentia-
tion of retinal cell in vitreous fluid [3, 4, 29, 32]. Thus,
differentiation and integration of the transplanted ADSCs in
the host environment is influenced by various growth factors
in vitreous body and retina. In addition, the various factors
also exist and influence differentiation and integration into
the retinal specific cell. In the present research, the trans-
planted ADSCs at 5, 10 PN displayed better morphological
and molecular differentiation and integration than that of
1 PN. The micro environment of the 5 and 10 PN retina is
distinct from the differentiation of the bipolar cells and
Müller cells in comparison to that of 1 PN [7]. The bipolar
cells and Müller cells are mainly differentiated at 5 and 10
PN. Mash1, Math3 and Chx10 are involved in the differen-
tiation of the bipolar cell in the developing retina. Rax,
Hes1, Hes5, Hesr2 and notch1 promote the formation of the
Müller cell [11, 12]. Thus, it is likely that the various factors
involved in the differentiation of the bipolar and Müller
cell can influence the differentiation and integration of the
transplanted ADSCs into the developing retina. For better
differentiation and integration of the ADSCs, the present
study suggests that the host micro environment at 5, 10 PN
eye should have specific signaling characters or a different
timing and strength of each signal. For example, it was re-
ported that one type of the matrix metalloproteinase (MMP),
MMP2, raised the survival rate of the transplantation and 17
beta-estradiol and concanavalin A facilitated the movement
of the transplanted cells [42]. In addition, retinoic acid (RA)
[16], neurocytokine ciliary neurotrophic factor (CNTF) [35]
and the glial cell line derived neurotrophic factor (GDNF)
[27] are all related with the photoreceptor survivals.
The ADSCs survived after xenotransplantation and the
Table 1. Morphological and phenotypic differentiation of human adipose derived stromal cells in the developing vitreous body and retina
+++; ≥30%, ++; 10~30%, +; 1~10%, −; rare
%=Cells of Morphological differentiation, Integration or Expression/Total survival transplanted cells ×100
1PN 5PN 10PN
7DPT 14DPT 28DPT 7DPT 14DPT 28DPT 7DPT 14DPT 28DPT
Morphological differentiation − − − +++ − − +++ ++ −
Integration −−− +−− +−−
Map2ab expression − − − + +− − + +− −
GFAP expression − − − + +− − + +− −Transplantation of Adipose Derived Stromal Cells 129
transplanted hosts had the absence of immunosuppression
in the present research. These could be due to the relative
purity of cultured ADSCs, which lack donor adipose
antigen-presenting cells and have no passenger leukocyte
induced transplant rejection [48].
To conclude, the present study demonstrated that the
transplanted ADSCs survived and showed morphological
and molecular differentiation with expressions of MAP2ab
and GFAP. Some of the transplanted cells integrated into the
host retina. The study also demonstrated how the developing
stage of the host environment influenced the differentiation
and integration of the transplanted ADSCs. The morpholog-
ical and molecular differentiation and the integration into the
retina were very limited in comparison to other stem cells.
However, the study provided some evidence for better
developmental stages and for the analysis of better micro
environmental signaling conditions for transplantation in the
future.
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